Comparison of uninterrupted direct oral anticoagulation with vitamin‐K antagonists during AF‐ablation in the clinical routine. A single center register. Issue 9 (26th July 2021)

• Record Type: Journal Article
• Authors: Christoph, Marian; Youssef, Akram; Svitil, Jan; Forkmann, Mathias; Huo, Yan; Gaspar, Thomas; Francke, Alexander; Schoen, Steffen; Quick, Silvio; Wunderlich, Carsten
• Is Part Of: Clinical cardiology. Volume 44:Issue 9(2021)
• Page Start: 1243
• Page End: 1248
• Publication Date: 2021-07-26
• Subjects: AF‐ablation -- heparin dosage -- oral anticoagulation -- periinterventional complications; Cardiology -- Periodicals; 616.12005
• DOI: 10.1002/clc.23676
• Languages: English
• ISSNs: 0160-9289

Abstract

Abstract: Background: Uninterrupted direct oral anticoagulation (DOAC) in AF‐ablation is recommended, proven by randomized trials. The outcome and the periinterventional differences between DOACs and VKA in the real world clinical practice are discussed controversial. Hypothesis: To investigate efficiency and safety of uninterrupted DOAC therapy compared to VKA during AF‐Ablation in real world setting with a focus on periinterventional heparin dosage.